Skip to main content
. 2017 Jan 4;8(6):9546–9556. doi: 10.18632/oncotarget.14488

Table 1. Summary of study population A and B.

Population A (Chinese) Population B (French)
Control (N = 52) CRA (N = 47) CRC (N = 42) P Control (N = 61) CRA (N = 27) CRC (N = 53) P
Age, years (mean ± SD) 52.29 ± 1.53 58.89 ± 1.48 62.88 ± 1.50 < 0.0001 60.57 ± 1.46 60.30 ± 1.67 66.81 ± 1.494 0.004
Gender (n,%) 0.544 0.190
Male 21(40%) 24(51%) 18(43%) 28(46%) 18(67%) 29(55%)
Female 31(60%) 23(49%) 24(57%) 33(54%) 9 (33%) 24(45%)
Positive FOBT (n,%) 7 (14%) 5 (11%) 16(38%) 0.002 3(5%) 4(15%) 26(49%) < 0.0001
TNM stages, I, II 12 17
TNM stages, III, IV 30 36